'NASA Freezes Human Aging': This Stunning Discovery Could Delay Death and Revolutionize Deep Space Survival Forever
IN A NUTSHELL 🚀 Researchers discover that necrosis —a chaotic form of cell death—holds the key to enhancing human aging and space travel.
—a chaotic form of cell death—holds the key to enhancing human aging and space travel. 🧬 Unlike programmed cell death, necrosis is messy and contagious , contributing to chronic diseases like Alzheimer's and cardiovascular decline.
, contributing to chronic diseases like Alzheimer's and cardiovascular decline. 🔬 Targeting necrosis could unlock new treatments for age-related diseases by breaking destructive cycles and allowing for healthy cell function.
🌌 Addressing necrosis in space could mitigate accelerated aging effects on astronauts, paving the way for longer missions and deeper exploration.
In a groundbreaking study, scientists have uncovered the potential role of necrosis in not only understanding human aging but also in enhancing the possibilities of deep space travel. Often dismissed as mere biological debris, necrosis—a chaotic form of unprogrammed cell death—has been revealed as a critical factor in tissue damage and systemic decline. Researchers from University College London, the biotech firm LinkGevity, and the European Space Agency argue that this understanding could pave the way for new treatments for chronic illnesses and provide a crucial tool for humans to survive in space. This discovery opens doors to revolutionary advances in medicine and space exploration. Understanding Necrosis: The Chaotic Cell Death
Necrosis is a form of cell death that occurs when cells are overwhelmed by injury, infection, or stress. This process floods cells with calcium, disrupting vital functions and causing the cell to rupture. The collapse spills toxic molecules into the surrounding tissue, triggering inflammation and accelerating damage. Unlike the well-ordered process of programmed cell death, necrosis is messy—and contagious. A single dying cell can spark a chain reaction in its neighbors, compounding degeneration over time.
Researchers believe this chaotic process may explain how chronic diseases such as Alzheimer's, kidney failure, and cardiovascular decline intensify with age. According to Dr. Keith Siew, necrosis has been largely overlooked as it was considered an endpoint. However, mounting evidence suggests it is a central mechanism through which systemic degeneration arises and spreads. By targeting necrosis, scientists hope to unlock new ways to treat conditions ranging from kidney failure to cardiac disease, neurodegeneration, and even aging itself.
'Einstein Was Right All Along': This Atomic Clock on the ISS Is Putting General Relativity to Its Ultimate Test Necrosis and Its Impact on Chronic Diseases
Dr. Carina Kern emphasizes that necrosis is not just the last stage of cell death but a critical point of convergence across many diseases. In many age-related illnesses—affecting organs such as the lungs, kidneys, liver, brain, and cardiovascular system—relentless cascades of necrosis fuel disease progression. This often occurs alongside impaired healing, leading to fibrosis, inflammation, and damaged cells. Each cascade triggers and amplifies the next, creating a vicious cycle of degeneration.
If scientists can target and manage necrosis, they could potentially transform the treatment of various chronic diseases. The key lies in breaking the destructive cycles that necrosis initiates, allowing for healthier cell function and possibly even regeneration. This approach could revolutionize the way we understand and treat degenerative conditions, offering hope for improved health outcomes in aging populations.
'Alien-Like Sea Creature Emerges': Extremely Rare Marine Species Seen for First Time Following 62-Mile Iceberg Detachment Challenges and Opportunities in Space Exploration
Necrosis presents a significant obstacle to human space exploration, as astronauts endure accelerated aging caused by microgravity and cosmic radiation. A 2024 study involving Dr. Siew highlighted the rapid deterioration of kidney function in low-gravity environments, raising concerns for long-duration space missions. Professor Damian Bailey suggests that addressing necrosis could transform longevity on Earth and push the frontiers of space exploration.
In space, factors that contribute to aging on Earth are exacerbated by cosmic radiation and microgravity, speeding up degeneration dramatically. If necrosis could be prevented, even temporarily, it would shut down destructive cycles at their source, enabling normal physiological processes and cell division to resume. This potential for regeneration could be a game-changer for long-term human survival in space, opening new horizons for exploration and discovery.
'Global Population Far Higher Than Expected': New Revelation Exposes Massive Undercount That Changes Everything About Our Future Future Implications and the Path Forward
The study of necrosis and its implications for aging and space travel has been published in Nature Oncogene, signaling a significant step forward in understanding this complex process. The collaborative efforts of scientists from various fields underscore the importance of interdisciplinary research in tackling global challenges. As science continues to unravel the mysteries of necrosis, the potential applications in medicine and space exploration are vast and promising.
With the possibility of targeting necrosis to treat chronic diseases and support human survival in space, the future of this research is both exciting and challenging. As we venture further into the unknown, what new discoveries about cell death and regeneration will shape the future of humanity, both on Earth and beyond?
Our author used artificial intelligence to enhance this article.
Did you like it? 4.6/5 (26)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sustainability Times
a day ago
- Sustainability Times
'NASA Freezes Human Aging': This Stunning Discovery Could Delay Death and Revolutionize Deep Space Survival Forever
IN A NUTSHELL 🚀 Researchers discover that necrosis —a chaotic form of cell death—holds the key to enhancing human aging and space travel. —a chaotic form of cell death—holds the key to enhancing human aging and space travel. 🧬 Unlike programmed cell death, necrosis is messy and contagious , contributing to chronic diseases like Alzheimer's and cardiovascular decline. , contributing to chronic diseases like Alzheimer's and cardiovascular decline. 🔬 Targeting necrosis could unlock new treatments for age-related diseases by breaking destructive cycles and allowing for healthy cell function. 🌌 Addressing necrosis in space could mitigate accelerated aging effects on astronauts, paving the way for longer missions and deeper exploration. In a groundbreaking study, scientists have uncovered the potential role of necrosis in not only understanding human aging but also in enhancing the possibilities of deep space travel. Often dismissed as mere biological debris, necrosis—a chaotic form of unprogrammed cell death—has been revealed as a critical factor in tissue damage and systemic decline. Researchers from University College London, the biotech firm LinkGevity, and the European Space Agency argue that this understanding could pave the way for new treatments for chronic illnesses and provide a crucial tool for humans to survive in space. This discovery opens doors to revolutionary advances in medicine and space exploration. Understanding Necrosis: The Chaotic Cell Death Necrosis is a form of cell death that occurs when cells are overwhelmed by injury, infection, or stress. This process floods cells with calcium, disrupting vital functions and causing the cell to rupture. The collapse spills toxic molecules into the surrounding tissue, triggering inflammation and accelerating damage. Unlike the well-ordered process of programmed cell death, necrosis is messy—and contagious. A single dying cell can spark a chain reaction in its neighbors, compounding degeneration over time. Researchers believe this chaotic process may explain how chronic diseases such as Alzheimer's, kidney failure, and cardiovascular decline intensify with age. According to Dr. Keith Siew, necrosis has been largely overlooked as it was considered an endpoint. However, mounting evidence suggests it is a central mechanism through which systemic degeneration arises and spreads. By targeting necrosis, scientists hope to unlock new ways to treat conditions ranging from kidney failure to cardiac disease, neurodegeneration, and even aging itself. 'Einstein Was Right All Along': This Atomic Clock on the ISS Is Putting General Relativity to Its Ultimate Test Necrosis and Its Impact on Chronic Diseases Dr. Carina Kern emphasizes that necrosis is not just the last stage of cell death but a critical point of convergence across many diseases. In many age-related illnesses—affecting organs such as the lungs, kidneys, liver, brain, and cardiovascular system—relentless cascades of necrosis fuel disease progression. This often occurs alongside impaired healing, leading to fibrosis, inflammation, and damaged cells. Each cascade triggers and amplifies the next, creating a vicious cycle of degeneration. If scientists can target and manage necrosis, they could potentially transform the treatment of various chronic diseases. The key lies in breaking the destructive cycles that necrosis initiates, allowing for healthier cell function and possibly even regeneration. This approach could revolutionize the way we understand and treat degenerative conditions, offering hope for improved health outcomes in aging populations. 'Alien-Like Sea Creature Emerges': Extremely Rare Marine Species Seen for First Time Following 62-Mile Iceberg Detachment Challenges and Opportunities in Space Exploration Necrosis presents a significant obstacle to human space exploration, as astronauts endure accelerated aging caused by microgravity and cosmic radiation. A 2024 study involving Dr. Siew highlighted the rapid deterioration of kidney function in low-gravity environments, raising concerns for long-duration space missions. Professor Damian Bailey suggests that addressing necrosis could transform longevity on Earth and push the frontiers of space exploration. In space, factors that contribute to aging on Earth are exacerbated by cosmic radiation and microgravity, speeding up degeneration dramatically. If necrosis could be prevented, even temporarily, it would shut down destructive cycles at their source, enabling normal physiological processes and cell division to resume. This potential for regeneration could be a game-changer for long-term human survival in space, opening new horizons for exploration and discovery. 'Global Population Far Higher Than Expected': New Revelation Exposes Massive Undercount That Changes Everything About Our Future Future Implications and the Path Forward The study of necrosis and its implications for aging and space travel has been published in Nature Oncogene, signaling a significant step forward in understanding this complex process. The collaborative efforts of scientists from various fields underscore the importance of interdisciplinary research in tackling global challenges. As science continues to unravel the mysteries of necrosis, the potential applications in medicine and space exploration are vast and promising. With the possibility of targeting necrosis to treat chronic diseases and support human survival in space, the future of this research is both exciting and challenging. As we venture further into the unknown, what new discoveries about cell death and regeneration will shape the future of humanity, both on Earth and beyond? Our author used artificial intelligence to enhance this article. Did you like it? 4.6/5 (26)
Euronews
3 days ago
- Euronews
A-ha's Morten Harket reveals he has Parkinson's disease
Morten Harket, frontman of celebrated Norwegian synth-pop band A-Ha, has revealed that he has Parkinson's disease. The news was shared by the band in a statement on their website which read: 'This isn't the sort of news anyone wants to deliver to the world, but here it is – Morten has Parkinson's disease.' The pop icon, aged 65, shared further details of the diagnosis in the post, and explained why he has sharing the news after previously keeping details on his health 'strictly private'. 'I've got no problem accepting the diagnosis. With time I've taken to heart my 94-year-old father's attitude to the way the organism gradually surrenders: 'I use whatever works',' he wrote. 'Part of me wanted to reveal it. Like I said, acknowledging the diagnosis wasn't a problem for me; it's my need for peace and quiet to work that has been stopping me. I'm trying the best I can to prevent my entire system from going into decline.' Harket said he underwent neurological procedures to have electrodes implanted inside his brain last year and that this had reduced the symptoms. He continued: 'It's a difficult balancing act between taking the medication and managing its side effects. There's so much to weigh up when you're emulating the masterful way the body handles every complex movement, or social matters and invitations, or day-to-day life in general.' Regarding whether Harket can still perform and sing, he wrote: 'I don't really know. I don't feel like singing, and for me that's a sign. I'm broadminded in terms of what I think works; I don't expect to be able to achieve full technical control. The question is whether I can express myself with my voice. As things stand now, that's out of the question. But I don't know whether I'll be able to manage it at some point in the future.' Parkinson's is the second most common neurodegenerative disorder in the world, behind Alzheimer's. It causes deterioration in the brain's nervous system, leading to tremors and other symptoms that can become progressively worse over time. Common symptoms include involuntary shaking, slower-than-usual movement, and stiffness in the muscles. The disease can be treated with surgery and medication, but there is no cure. It is not known what exactly leads to people developing the condition. Other famous faces who have had Parkinson's diagnoses include Back To The Future actor Michael J. Fox, heavy metal legend Ozzy Osbourne and Scottish comedian Billy Connolly. In a true David versus Goliath struggle in the business world, the French conglomerate Louis Vuitton has launched an intellectual property lawsuit against the Portuguese liqueur producer, Licores do Vale. The French firm says the Monção company's use of an LV (with an inverted V) on the labels of its bottles, and a graphic for its brand's communications, are too similar to the one used by the fashion house in its productions. The action was brought before Intellectual Property Court in order to challenge the registration of the Portuguese brand by the National Institute of Industrial Property. According to the lawsuit filed and quoted by Jornal de Notícias, Louis Vuitton accuses Licores do Vale of "parasitically exploiting the prestige of a third party's brand", and creating "unfair competition" with an "identical or similar" symbol. The French giant says that it is "an almost total reproduction" at "verbal, phonetic and conceptual" level and that it has registered products in the same category, thus reinforcing the alleged similarities. A post shared by Licores do Vale (@_licores_do_vale) Licores do Vale producer, André Ferreira told Jornal de Notícias, that he developed the logo together with his girlfriend in order to promote the product at small agricultural fairs in the region. "The L is for liqueurs and the V is for valley, it was turned upside down to symbolise the mountains surrounding the parish [of Longos Vales] and the little leaves represent nature," he said. Ferreira, a metrology technician, who is trying to take his first steps in the world of artisanal production, says he was "surprised" by the measure, emphasising that the products are not on sale for now. "This is a hobby. We've only just begun and started straight away with this entry. The Louis Vuitton logo and the Licores do Vale logo have nothing to do with each other." Ferreira applied to register the trade mark in August 2024 and it was granted in January 2025. At the time, Louis Vuitton "prioritised international trademark registrations", with no consequences for the small Portuguese producer, who saw his application accepted. Even so, and despite the registration having been approved, the legal appeal now lodged by Louis Vuitton puts that registration on hold, leaving "Licores do Vale" in limbo. On social media, particularly Instagram, many users have shown their support for the small Portuguese producer, encouraging him to continue his business and even to take advantage of the media coverage generated by the case. On Instagram, where liqueurs of different flavours are discussed, the small business has just over 1,000 followers. Louis Vuitton, a French brand with 170 years of history, has more than 55 million followers on Instagram alone.
Euronews
3 days ago
- Euronews
Neurotech will reshape how we live, predicts CEO Ana Maiques
Neurological conditions affected more than 3 billion people worldwide in 2021, according to a major study published in The Lancet in 2024. These conditions impact the nervous system and comprise a wide variety of disorders, including epilepsy, Alzheimer's disease, Parkinson's disease, dementia and many others. Today, neurological diseases are the leading cause of illness and disability worldwide, and beyond the toll they take on patients and their loved ones, they also impose a significant economic burden. According to another study published in The Lancet, brain disorders are projected to cost the global economy 16 trillion dollars between 2010 and 2030, a figure largely driven by the early onset of these conditions and the resulting long-term loss of productivity. Given the need for research and treatment of brain disorders, some companies are investing in this area to advance our understanding of the brain. Among the most high-profile is Neuralink, founded by Elon Musk in 2016. However, Europe has also emerged as a powerhouse in neurotechnology. A notable example is the Spanish company Neuroelectrics, launched by Ana Maiques and Giulio Ruffini in 2011. Over the years, Neuroelectrics has expanded from its European roots to establish a presence in the United States, becoming an international leader in the field. Ana Maiques, CEO of Neuroelectrics, joined My Wildest Prediction to share her boldest insights and vision for the future of brain technology. My Wildest Prediction is a podcast series from Euronews Businesswhere we dare to imagine the future with business and tech visionaries. In this episode, Tom Goodwin talks to Ana Maiques, CEO and Co-Founder of Neuroelectrics. 'My wildest prediction is that neurotechnology is going to impact our daily lives in ways we cannot even imagine,' Ana Maiques told Euronews Business. Maiques clarified that neurotechnology tools should and will not be used to enhance individual traits such as intelligence or reverse ageing. However, she believes these tools will be applied to treat medical conditions, broaden people's experience of reality and strengthen our general understanding of how the brain works. 'A lot of people approach us! (...) We have a paper written with Refik Anadol where we monitored the impact on the visitors' brains of his AI-generated sculptures. Now, we are talking with Michelin-star chefs who want to study the impact of food on the brain from a scientific perspective,' she explained. Maiques acknowledged the fears some people have about using electricity in the brain but emphasised that much of this concern stems from a lack of understanding of the real, positive impact neurotechnology can have. Unlike Neuralink, which develops in-brain implants, Neuroeletrics takes a non–invasive approach, using external tools to monitor and interact with the brain. Neuroelectrics' standout product is the Neoprane Headcap. The cap features electrodes connected to a wireless module located in the back. These electrodes can both monitor the brain activity and deliver electrical stimulation. This tool can help diagnose sleep disorders, epilepsy, and other neurological conditions. It is especially useful in hospital settings where electroencephalogram (EEG) equipment may not be available or where technicians are not present. To develop these tools, Neuroelectrics has been using machine learning and AI for years. 'There is no way we can, as humans, decode the brain without the help of these kinds of tools,' Ana Maiques said. The CEO noted that advancements in AI could lead to the potential modelling of the brain, raising many ethical and scientific questions. However, she emphasised the importance of continued experimentation, as achieving a complete scientific understanding of the brain remains highly complex. Washington has doubled its tariffs on steel and aluminium to 50% as President Donald Trump seeks to exclude foreign producers from the US market. The directive, which the White House shared on X, claimed that the rise would 'provide greater support' to US industries, and would 'eliminate the national security threat' posed by imported steel and aluminium. 'Nobody is going to get around that,' Trump said when first discussing the raise at a rally in Pennsylvania last Friday. 'At 25%, they can sort of get over that fence. At 50% they can no longer get over the fence.' While Washington claims that excluding foreign producers will support employment in the US, critics argue that it also jeopardises domestic jobs. As materials become more expensive and the price of production rises, US firms may let go of staff to trim costs. It's estimated that steel and aluminium tariffs introduced during Trump's first term in 2018 destroyed 75,000 US manufacturing jobs, while creating 1,000 extra jobs in the steel industry. Wednesday's tariff hike also creates added friction with international trade partners ahead of Trump's 9 July deadline, when his so-called 'reciprocal' tariff pause will end. In April, Trump temporarily halted proposed duties on a number of countries. The president's team at the time said they were aiming for '90 deals in 90 days'. So far, the US has only managed to secure a trade deal with the UK, meaning that British steel and aluminium producers will continue to pay a rate of 25% — at least for now. The president's tariff proposals also faced a significant legal blow last week. The New York-based Court of International Trade and a federal court in Washington DC ruled that Trump did not have the authority to impose tariffs on nearly every one of the world's countries — a battle predicted to end up in the Supreme Court. Steel and aluminium levies were not part of that ruling, although Washington will likely want to show its determination to push ahead with duties. As the latest hike comes into effect, EU trade Commissioner Maroš Šefčovič will meet his US counterpart Ambassador Jamieson Greer on Wednesday on the sidelines of an OECD meeting in Paris.
